JPH022327A - Sweetener having heterocyclic group - Google Patents
Sweetener having heterocyclic groupInfo
- Publication number
- JPH022327A JPH022327A JP63318352A JP31835288A JPH022327A JP H022327 A JPH022327 A JP H022327A JP 63318352 A JP63318352 A JP 63318352A JP 31835288 A JP31835288 A JP 31835288A JP H022327 A JPH022327 A JP H022327A
- Authority
- JP
- Japan
- Prior art keywords
- sweetener
- group
- acid
- sodium
- sucrose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000003599 food sweetener Nutrition 0.000 title claims abstract description 43
- 239000003765 sweetening agent Substances 0.000 title claims abstract description 43
- 125000000623 heterocyclic group Chemical group 0.000 title claims description 10
- 229930006000 Sucrose Natural products 0.000 claims abstract description 35
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims abstract description 35
- 239000005720 sucrose Substances 0.000 claims abstract description 35
- -1 2-cyanopyrimidin-5-yl Chemical group 0.000 claims abstract description 18
- 235000021147 sweet food Nutrition 0.000 claims abstract description 4
- 125000002618 bicyclic heterocycle group Chemical group 0.000 claims abstract 2
- 125000000896 monocarboxylic acid group Chemical group 0.000 claims abstract 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 26
- 239000000203 mixture Substances 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 10
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 9
- 239000011734 sodium Substances 0.000 claims description 9
- 229910052708 sodium Inorganic materials 0.000 claims description 9
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 8
- 239000002537 cosmetic Substances 0.000 claims description 8
- 239000011591 potassium Substances 0.000 claims description 8
- 229910052700 potassium Inorganic materials 0.000 claims description 8
- 238000002360 preparation method Methods 0.000 claims description 8
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 claims description 7
- 239000002253 acid Substances 0.000 claims description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 6
- 159000000007 calcium salts Chemical class 0.000 claims description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 6
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 4
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 4
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 4
- 229930195725 Mannitol Natural products 0.000 claims description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 4
- DLRVVLDZNNYCBX-UHFFFAOYSA-N Polydextrose Polymers OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(O)O1 DLRVVLDZNNYCBX-UHFFFAOYSA-N 0.000 claims description 4
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims description 4
- 235000013361 beverage Nutrition 0.000 claims description 4
- 235000015218 chewing gum Nutrition 0.000 claims description 4
- 235000009508 confectionery Nutrition 0.000 claims description 4
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 claims description 4
- 239000000594 mannitol Substances 0.000 claims description 4
- 235000010355 mannitol Nutrition 0.000 claims description 4
- 125000002950 monocyclic group Chemical group 0.000 claims description 4
- 239000000600 sorbitol Substances 0.000 claims description 4
- 235000010356 sorbitol Nutrition 0.000 claims description 4
- 239000000126 substance Substances 0.000 claims description 4
- 239000001913 cellulose Substances 0.000 claims description 3
- 229920002678 cellulose Polymers 0.000 claims description 3
- 235000010980 cellulose Nutrition 0.000 claims description 3
- 239000000945 filler Substances 0.000 claims description 3
- 239000008101 lactose Substances 0.000 claims description 3
- 229920000609 methyl cellulose Polymers 0.000 claims description 3
- 239000001923 methylcellulose Substances 0.000 claims description 3
- 235000010981 methylcellulose Nutrition 0.000 claims description 3
- 239000000892 thaumatin Substances 0.000 claims description 3
- 235000010436 thaumatin Nutrition 0.000 claims description 3
- NUFKRGBSZPCGQB-FLBSXDLDSA-N (3s)-3-amino-4-oxo-4-[[(2r)-1-oxo-1-[(2,2,4,4-tetramethylthietan-3-yl)amino]propan-2-yl]amino]butanoic acid;pentahydrate Chemical compound O.O.O.O.O.OC(=O)C[C@H](N)C(=O)N[C@H](C)C(=O)NC1C(C)(C)SC1(C)C.OC(=O)C[C@H](N)C(=O)N[C@H](C)C(=O)NC1C(C)(C)SC1(C)C NUFKRGBSZPCGQB-FLBSXDLDSA-N 0.000 claims description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims description 2
- 239000004377 Alitame Substances 0.000 claims description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 2
- 108010011485 Aspartame Proteins 0.000 claims description 2
- 239000005711 Benzoic acid Substances 0.000 claims description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims description 2
- 239000004378 Glycyrrhizin Substances 0.000 claims description 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 2
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims description 2
- 239000005913 Maltodextrin Substances 0.000 claims description 2
- 229920002774 Maltodextrin Polymers 0.000 claims description 2
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims description 2
- 108050004114 Monellin Proteins 0.000 claims description 2
- 229920001100 Polydextrose Polymers 0.000 claims description 2
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 claims description 2
- 229920002472 Starch Polymers 0.000 claims description 2
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 claims description 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 claims description 2
- 240000008042 Zea mays Species 0.000 claims description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 2
- 235000019409 alitame Nutrition 0.000 claims description 2
- 108010009985 alitame Proteins 0.000 claims description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 2
- 239000000605 aspartame Substances 0.000 claims description 2
- 235000010357 aspartame Nutrition 0.000 claims description 2
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 claims description 2
- 229960003438 aspartame Drugs 0.000 claims description 2
- 235000010233 benzoic acid Nutrition 0.000 claims description 2
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 claims description 2
- 239000011575 calcium Substances 0.000 claims description 2
- 229910052791 calcium Inorganic materials 0.000 claims description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims description 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims description 2
- 229940112822 chewing gum Drugs 0.000 claims description 2
- 235000005822 corn Nutrition 0.000 claims description 2
- QGGZBXOADPVUPN-UHFFFAOYSA-N dihydrochalcone Chemical compound C=1C=CC=CC=1C(=O)CCC1=CC=CC=C1 QGGZBXOADPVUPN-UHFFFAOYSA-N 0.000 claims description 2
- PXLWOFBAEVGBOA-UHFFFAOYSA-N dihydrochalcone Natural products OC1C(O)C(O)C(CO)OC1C1=C(O)C=CC(C(=O)CC(O)C=2C=CC(O)=CC=2)=C1O PXLWOFBAEVGBOA-UHFFFAOYSA-N 0.000 claims description 2
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 claims description 2
- 235000011187 glycerol Nutrition 0.000 claims description 2
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 claims description 2
- 229960004949 glycyrrhizic acid Drugs 0.000 claims description 2
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 claims description 2
- 235000019410 glycyrrhizin Nutrition 0.000 claims description 2
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims description 2
- 150000002525 isomaltoses Chemical class 0.000 claims description 2
- 159000000003 magnesium salts Chemical class 0.000 claims description 2
- 229940035034 maltodextrin Drugs 0.000 claims description 2
- 235000014594 pastries Nutrition 0.000 claims description 2
- 239000001259 polydextrose Substances 0.000 claims description 2
- 235000013856 polydextrose Nutrition 0.000 claims description 2
- 229940035035 polydextrose Drugs 0.000 claims description 2
- 235000019260 propionic acid Nutrition 0.000 claims description 2
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 claims description 2
- 235000019204 saccharin Nutrition 0.000 claims description 2
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 claims description 2
- 229940081974 saccharin Drugs 0.000 claims description 2
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 claims description 2
- 239000004334 sorbic acid Substances 0.000 claims description 2
- 235000010199 sorbic acid Nutrition 0.000 claims description 2
- 229940075582 sorbic acid Drugs 0.000 claims description 2
- 239000008107 starch Substances 0.000 claims description 2
- 235000019698 starch Nutrition 0.000 claims description 2
- 229940032147 starch Drugs 0.000 claims description 2
- 229940013618 stevioside Drugs 0.000 claims description 2
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 claims description 2
- 235000019202 steviosides Nutrition 0.000 claims description 2
- 239000006188 syrup Substances 0.000 claims description 2
- 235000020357 syrup Nutrition 0.000 claims description 2
- 239000011975 tartaric acid Substances 0.000 claims description 2
- 235000002906 tartaric acid Nutrition 0.000 claims description 2
- 229940083542 sodium Drugs 0.000 claims 4
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 claims 2
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 claims 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims 1
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 claims 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 claims 1
- 229930091371 Fructose Natural products 0.000 claims 1
- 239000005715 Fructose Substances 0.000 claims 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims 1
- 235000010358 acesulfame potassium Nutrition 0.000 claims 1
- 239000000619 acesulfame-K Substances 0.000 claims 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims 1
- 229940105329 carboxymethylcellulose Drugs 0.000 claims 1
- 235000015165 citric acid Nutrition 0.000 claims 1
- 239000001530 fumaric acid Substances 0.000 claims 1
- 235000011087 fumaric acid Nutrition 0.000 claims 1
- 239000008103 glucose Substances 0.000 claims 1
- 235000001727 glucose Nutrition 0.000 claims 1
- 229920000591 gum Polymers 0.000 claims 1
- 229920003063 hydroxymethyl cellulose Polymers 0.000 claims 1
- 229940031574 hydroxymethyl cellulose Drugs 0.000 claims 1
- 235000005772 leucine Nutrition 0.000 claims 1
- 229960002900 methylcellulose Drugs 0.000 claims 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims 1
- 239000008108 microcrystalline cellulose Substances 0.000 claims 1
- 229940016286 microcrystalline cellulose Drugs 0.000 claims 1
- 239000001814 pectin Substances 0.000 claims 1
- 235000010987 pectin Nutrition 0.000 claims 1
- 229920001277 pectin Polymers 0.000 claims 1
- 229960000292 pectin Drugs 0.000 claims 1
- 235000011007 phosphoric acid Nutrition 0.000 claims 1
- 239000000661 sodium alginate Substances 0.000 claims 1
- 235000010413 sodium alginate Nutrition 0.000 claims 1
- 229940005550 sodium alginate Drugs 0.000 claims 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 16
- 235000014171 carbonated beverage Nutrition 0.000 abstract description 4
- 235000014214 soft drink Nutrition 0.000 abstract description 2
- 125000006519 CCH3 Chemical group 0.000 abstract 1
- 125000002911 monocyclic heterocycle group Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 description 35
- 239000000243 solution Substances 0.000 description 34
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 21
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 18
- 238000002844 melting Methods 0.000 description 16
- 230000008018 melting Effects 0.000 description 16
- 239000000047 product Substances 0.000 description 14
- 238000003786 synthesis reaction Methods 0.000 description 13
- UCMIRNVEIXFBKS-UHFFFAOYSA-N beta-alanine Chemical compound NCCC(O)=O UCMIRNVEIXFBKS-UHFFFAOYSA-N 0.000 description 12
- 230000015572 biosynthetic process Effects 0.000 description 12
- 229940000635 beta-alanine Drugs 0.000 description 10
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 9
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 239000007787 solid Substances 0.000 description 9
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 8
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 6
- 230000003796 beauty Effects 0.000 description 6
- 150000003839 salts Chemical group 0.000 description 6
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 5
- 150000002148 esters Chemical class 0.000 description 5
- 239000007791 liquid phase Substances 0.000 description 5
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 239000002244 precipitate Substances 0.000 description 4
- YEMNJNGLOLLMOJ-UHFFFAOYSA-N 3-(pyridin-4-ylcarbamoylamino)propanoic acid Chemical compound OC(=O)CCNC(=O)NC1=CC=NC=C1 YEMNJNGLOLLMOJ-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 3
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Natural products NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 3
- 206010022998 Irritability Diseases 0.000 description 3
- 238000009835 boiling Methods 0.000 description 3
- 125000002837 carbocyclic group Chemical group 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 125000004494 ethyl ester group Chemical group 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 229960002449 glycine Drugs 0.000 description 3
- 239000012948 isocyanate Substances 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- NGQDFSBXXWJPQW-UHFFFAOYSA-N 2-[[amino-(5-amino-2-chloropyridin-3-yl)methylidene]amino]acetic acid Chemical compound NC1=CN=C(Cl)C(C(=N)NCC(O)=O)=C1 NGQDFSBXXWJPQW-UHFFFAOYSA-N 0.000 description 2
- YELFOYCFQBUTGF-UHFFFAOYSA-N 3-[(6-chloropyridin-3-yl)carbamoylamino]propanoic acid Chemical compound OC(=O)CCNC(=O)NC1=CC=C(Cl)N=C1 YELFOYCFQBUTGF-UHFFFAOYSA-N 0.000 description 2
- DCDCBPUCBIRRCE-UHFFFAOYSA-N 5-isocyanato-2,1,3-benzoxadiazole Chemical compound C1=C(N=C=O)C=CC2=NON=C21 DCDCBPUCBIRRCE-UHFFFAOYSA-N 0.000 description 2
- 206010013911 Dysgeusia Diseases 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 2
- MCHZUJIHVUVYCV-UHFFFAOYSA-N N=C=O.CCOC(=O)CCN Chemical compound N=C=O.CCOC(=O)CCN MCHZUJIHVUVYCV-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 229960000583 acetic acid Drugs 0.000 description 2
- 235000004279 alanine Nutrition 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 125000002619 bicyclic group Chemical group 0.000 description 2
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 238000009833 condensation Methods 0.000 description 2
- 230000005494 condensation Effects 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 229940093915 gynecological organic acid Drugs 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 150000002513 isocyanates Chemical class 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- 239000012086 standard solution Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 235000012094 sugar confectionery Nutrition 0.000 description 2
- SJMDMGHPMLKLHQ-UHFFFAOYSA-N tert-butyl 2-aminoacetate Chemical compound CC(C)(C)OC(=O)CN SJMDMGHPMLKLHQ-UHFFFAOYSA-N 0.000 description 2
- KAJICSGLHKRDLN-UHFFFAOYSA-N 1,3-dicyclohexylthiourea Chemical compound C1CCCCC1NC(=S)NC1CCCCC1 KAJICSGLHKRDLN-UHFFFAOYSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- KTNBGCQNMWKCPD-UHFFFAOYSA-N 2,1,3-benzoxadiazol-5-ylthiourea Chemical compound C1=C(NC(=S)N)C=CC2=NON=C21 KTNBGCQNMWKCPD-UHFFFAOYSA-N 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- INXQCPVYQRLNFJ-UHFFFAOYSA-N 3-(2,1,3-benzoxadiazol-5-ylcarbamoylamino)propanoic acid Chemical compound C1=C(NC(=O)NCCC(=O)O)C=CC2=NON=C21 INXQCPVYQRLNFJ-UHFFFAOYSA-N 0.000 description 1
- SMMCYIHCDOLFDU-UHFFFAOYSA-N 3-[[(2,1,3-benzoxadiazol-5-ylamino)-(cyanoamino)methylidene]amino]propanoic acid Chemical compound C1=C(NC(NCCC(=O)O)=NC#N)C=CC2=NON=C21 SMMCYIHCDOLFDU-UHFFFAOYSA-N 0.000 description 1
- XUUUEYOOFLBVMD-UHFFFAOYSA-N 3-aminopropanoic acid hydrate Chemical compound O.NCCC(O)=O XUUUEYOOFLBVMD-UHFFFAOYSA-N 0.000 description 1
- NUKYPUAOHBNCPY-UHFFFAOYSA-N 4-aminopyridine Chemical compound NC1=CC=NC=C1 NUKYPUAOHBNCPY-UHFFFAOYSA-N 0.000 description 1
- CNPURSDMOWDNOQ-UHFFFAOYSA-N 4-methoxy-7h-pyrrolo[2,3-d]pyrimidin-2-amine Chemical compound COC1=NC(N)=NC2=C1C=CN2 CNPURSDMOWDNOQ-UHFFFAOYSA-N 0.000 description 1
- NOMODHWDBMCWFQ-UHFFFAOYSA-N 5-aminopyrimidine-2-carbonitrile Chemical compound NC1=CN=C(C#N)N=C1 NOMODHWDBMCWFQ-UHFFFAOYSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- 235000016068 Berberis vulgaris Nutrition 0.000 description 1
- 241000335053 Beta vulgaris Species 0.000 description 1
- 101100037762 Caenorhabditis elegans rnh-2 gene Proteins 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- XZMCDFZZKTWFGF-UHFFFAOYSA-N Cyanamide Chemical compound NC#N XZMCDFZZKTWFGF-UHFFFAOYSA-N 0.000 description 1
- 240000004670 Glycyrrhiza echinata Species 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- 238000004566 IR spectroscopy Methods 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- YGCFIWIQZPHFLU-UHFFFAOYSA-N acesulfame Chemical compound CC1=CC(=O)NS(=O)(=O)O1 YGCFIWIQZPHFLU-UHFFFAOYSA-N 0.000 description 1
- 229960005164 acesulfame Drugs 0.000 description 1
- 239000003929 acidic solution Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 235000015173 baked goods and baking mixes Nutrition 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 239000004067 bulking agent Substances 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 238000006482 condensation reaction Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 125000000753 cycloalkyl group Chemical group 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000000921 elemental analysis Methods 0.000 description 1
- 238000002481 ethanol extraction Methods 0.000 description 1
- GLSWVTQCVGSOKF-UHFFFAOYSA-N ethyl 3-(1h-indazol-6-ylcarbamothioylamino)propanoate Chemical compound CCOC(=O)CCNC(=S)NC1=CC=C2C=NNC2=C1 GLSWVTQCVGSOKF-UHFFFAOYSA-N 0.000 description 1
- ZARDKVSZYDHYDG-UHFFFAOYSA-N ethyl 3-(pyridin-4-ylcarbamoylamino)propanoate Chemical compound CCOC(=O)CCNC(=O)NC1=CC=NC=C1 ZARDKVSZYDHYDG-UHFFFAOYSA-N 0.000 description 1
- RJCGNNHKSNIUAT-UHFFFAOYSA-N ethyl 3-aminopropanoate;hydron;chloride Chemical compound Cl.CCOC(=O)CCN RJCGNNHKSNIUAT-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 229960004979 fampridine Drugs 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- 235000019656 metallic taste Nutrition 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- VBEGHXKAFSLLGE-UHFFFAOYSA-N n-phenylnitramide Chemical compound [O-][N+](=O)NC1=CC=CC=C1 VBEGHXKAFSLLGE-UHFFFAOYSA-N 0.000 description 1
- 235000019520 non-alcoholic beverage Nutrition 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 239000012047 saturated solution Substances 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- MYMZLBHZVRWYRE-UHFFFAOYSA-N suosan Chemical compound OC(=O)CCNC(=O)NC1=CC=C([N+]([O-])=O)C=C1 MYMZLBHZVRWYRE-UHFFFAOYSA-N 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/14—Thiadiazoles; Hydrogenated thiadiazoles condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/30—Artificial sweetening agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/84—Nitriles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
- C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/12—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S426/00—Food or edible material: processes, compositions, and products
- Y10S426/804—Low calorie, low sodium or hypoallergic
Abstract
Description
【発明の詳細な説明】
「産業上の利用分野」
本発明は、特に甘味食品、飲料、砂糖菓子、パン菓子、
チューインガム、衛生製品、化粧品、化粧備品及び、薬
学及び獣医的製品等の使用に有用な複素環式基を持つ甘
味剤に関し、このような甘味剤を含む調製品及び組成物
に関する。Detailed Description of the Invention "Field of Industrial Application" The present invention is particularly applicable to sweet foods, beverages, sugar confectionery, bread confectionery,
The present invention relates to sweeteners with heterocyclic groups useful for use in chewing gums, hygiene products, cosmetics, cosmetic supplies, pharmaceutical and veterinary products, etc., and to preparations and compositions containing such sweeteners.
「従来の技術」
甘味特性を示す化学合成物の中で、「スオーサン(5g
osan)J及びその誘導体は、1948年ピーターソ
ン及びミューラ氏によって発見されてから、広範囲に研
究された化学シリーズを構成している。``Prior art'' Among the chemical compounds that exhibit sweetness properties, ``Suosan'' (5g
osan) J and its derivatives constitute a chemical series that has been extensively studied since its discovery by Peterson and Mueller in 1948.
例えば、ビート氏の「ヒトの化学感覚における構造及び
活性の関係」アプライド サイエンス1978年336
〜337頁発行ロンドン、クロスピ及びウィンガード氏
の「甘味料の進歩」アプライド サイエンス1979年
160頁発行ロンドン、チンチ、ノフレ及びベイタビ氏
の2.Lebeasm、Ulers、Forsch、
1982年175巻266〜268頁参照。しかし、こ
れら合成物は、あるものが強い毒性分子即ちこの場合4
−ニトロアニリンを遊離するので、商業的に使用されな
かった。更に、これら合成物は、(pH2,5〜3)の
酸性p)lの溶液、従って、甘味料の主要市場を構成す
る炭酸飲料(ソフトドリンク)を通常に甘味付ける使用
状態において僅かしか溶解しなかった。For example, Mr. Beet, “Structure and activity relationships in human chemosensation,” Applied Science 1978, 336.
"Advances in Sweeteners" published by London, Crospi and Wingard, pp. 337, Applied Science, 1979, pp. 160, published by London, Cinch, Nofre and Beitabi, 2. Lebeasm, Ulers, Forsch,
See 1982, Vol. 175, pp. 266-268. However, some of these compounds contain highly toxic molecules, in this case 4
- Not used commercially because it liberates nitroaniline. Moreover, these compounds are only slightly soluble in acidic p)l solutions of (pH 2.5-3), the conditions of use that normally sweeten carbonated beverages (soft drinks), which therefore constitute the main market for sweeteners. There wasn't.
米国特許出願第836,071号には、以下の般式の甘
味剤が開示されている。US Patent Application No. 836,071 discloses sweeteners of the following general formula.
但し、Aは、N、N+或はCで、N+がca−i、:よ
って塩化でき、
mは、AがNの時にl、AがN″″或はCの時に2であ
り、
nは、l或は2であり、
Bは、nが1の時に、CN、H,No、、OCH、或は
5O2Rで、Rが10までの炭素原子を持つアルキル、
シクロアルキル或はアリル基であり、
nが2の時に、CN、H或はOCH,であり、
Xは、BがCN、H或はOCH3の時に、CN或はNO
□であり、
BがNo、或は5o2Rの時に、CIl、CN。However, A can be N, N+ or C, and N+ can be ca-i: Therefore, m is l when A is N, 2 when A is N'''' or C, and n is , l or 2, B is CN, H, No, , OCH, or 5O2R when n is 1, and R is alkyl having up to 10 carbon atoms,
is a cycloalkyl or allyl group, when n is 2, it is CN, H or OCH, and when B is CN, H or OCH3, X is CN or NO
□, and when B is No or 5o2R, CIl, CN.
COCHs、F、H或はNo、であり、Mは、H,Nl
、K、NH4,l/2Ca或はl/2Mg基である新規
な甘味剤が提案されている。COCHs, F, H or No, M is H, Nl
, K, NH4, l/2Ca or l/2Mg groups have been proposed.
[発明が解決しようとする課題」
スオーサン及び誘導体及び米国特許出願第836.07
1号に記載した甘味剤においては、特に、合成甘味剤の
主要市場を構成する炭酸飲料等のソフトドリンクに保有
されているpH2,5〜3の状態で余りにも僅かしか溶
解しなかった。[Problem to be Solved by the Invention] Suosan and Derivatives and U.S. Patent Application No. 836.07
In particular, the sweetener described in No. 1 dissolved too little at a pH of 2.5 to 3, which is present in soft drinks such as carbonated drinks, which constitute the main market for synthetic sweeteners.
[課題を解決するための手段」
本発明による改良甘味剤はこのような欠点を解消するこ
とを目的としている。[Means for Solving the Problems] The improved sweetener according to the present invention aims to eliminate these drawbacks.
本発明の甘味剤は、以下の一般式を持ち、但し、Rは、
単環或は二環式である複素環式基であり、
前記単環式基が以下の群から選択され、但し、Xは、C
M、CN或はNO2基であり、前記二環式基が以下の群
から選択され、R−NHC−NH−(CH2)、−B
但し、G、がCH或はNであり、
G2がCH2、C01NH,NCH,,0女はSであり
、
G、及びG、がCH,CCH,、N或はNoであり、前
記Aは、0、S、NH或はN−CNで、NHが塩酸塩形
態で塩化され、
前記nは、l或は2であり、
前記Bは、C0OH或はナトリウム、カリウム、アンモ
ニウム、カルシウム或はマグネシウム塩であることを特
徴としている。The sweetener of the present invention has the following general formula, where R is
a heterocyclic group that is monocyclic or bicyclic, the monocyclic group being selected from the following group, provided that X is C
M, CN or NO2 group, the bicyclic group is selected from the following group, R-NHC-NH-(CH2), -B provided that G is CH or N, G2 is CH2 ,C01NH,NCH,,0 female is S, G and G are CH, CCH,, N or No, the A is 0, S, NH or N-CN, NH is hydrochloric acid It is characterized in that it is chlorinated in a salt form, the n is 1 or 2, and the B is COOH or a sodium, potassium, ammonium, calcium or magnesium salt.
換言すれば、本発明の甘味剤は、スオーサン或まその誘
導体及び米国特許出願第836,071号に記載された
甘味剤から、炭素環基(XCiH4)を異種環基即ち複
素環基(R)に置換した点が異なり、この差異が水の溶
解性、特に炭酸飲料に使用した場合のpHレベル(pH
2,5〜3)での酸状態での溶解性の増加の効果を持っ
ている。In other words, the sweeteners of the present invention are derived from Suosan or its derivatives and the sweeteners described in U.S. Patent Application No. 836,071 by replacing a carbocyclic group (XCiH4) with a heterocyclic group, i.e., a heterocyclic group (R). The difference is that it has been replaced with
2,5-3) has the effect of increasing solubility in acid conditions.
更に、炭素環基(X−C,H,)を異種環基即ち複素環
基(R)に置換したことは、甘味剤の甘味度を僅かに改
良しているが、甘味剤の分子構造の例え1菫かな改変は
、構造及び甘味活性間の関係が殆ど予測できない甘味特
性を抑制することとなる常識を考慮しても全く予期でき
なかった。M、G。Furthermore, substituting a carbocyclic group (X-C, H,) with a heterocyclic group (R) slightly improves the sweetness of the sweetener, but it does not change the molecular structure of the sweetener. Even a single violet modification was totally unexpected given the common sense that it would suppress sweetness properties where the relationship between structure and sweetness activity is poorly predictable. M.G.
J、ビーツ氏の「ヒトの化学感覚における構造と活性と
の関係」応用科学、発行ロンドン1978年259〜3
62頁参照。J. Beetz, Structure-Activity Relationships in Human Chemosensation, Applied Science, Published London 1978, 259-3.
See page 62.
有利には、本発明による甘味度において、Rは、2−シ
アノピリド−5−ニル基或は2−シアノピリミジン−5
−ニル基であり、
前記Aが0或はNHであり、
前記nは、AがNHである時に1、或はAがOである時
に2である。Advantageously, in the sweetness according to the invention R is a 2-cyanopyrid-5-yl group or a 2-cyanopyrimidine-5
-nyl group, the above A is 0 or NH, and the above n is 1 when A is NH, or 2 when A is O.
勿論、本発明は、本発明による1種類以上の甘味度の適
量を添加することによって、甘味食品、飲料、キャンデ
、パン菓子、チューインガム、衛生製品、化粧品、化粧
備品、薬学および獣医学的調製品等を形成した方法に関
する。適量即ち「有効量」とは、甘み感覚を形成するに
十分な甘味剤の量を指している。Of course, the present invention can also be used to prepare sweet foods, beverages, candies, pastries, chewing gums, sanitary products, cosmetics, toiletries, pharmaceutical and veterinary preparations by adding appropriate amounts of one or more sweetness levels according to the invention. Regarding the method of forming etc. A suitable or "effective amount" refers to an amount of sweetener sufficient to produce a sweet sensation.
本発明は、勿論、本発明による方法により甘味づけられ
た調製品に関する。The invention, of course, relates to preparations sweetened by the method according to the invention.
勿論、本発明は、本発明による少なくとも1種の甘味剤
の有効量と、最適な担体或は増量(充填)剤とからなる
甘味組成物に関する。The present invention, of course, relates to sweetening compositions comprising an effective amount of at least one sweetening agent according to the invention and a suitable carrier or bulking agent.
勿論、本発明は、本発明による1種以上の有効量の甘味
剤と、1種以上の他の甘味剤とからなることを特徴とす
る甘味組成物に関する。The invention, of course, relates to a sweetening composition characterized in that it consists of an effective amount of one or more sweetening agents according to the invention and one or more other sweetening agents.
本発明の甘味剤によって甘くなった製品は、甘味成分が
要望される全製品を備え、特にヒト或は動物消費用の食
物、アルコール飲料、非アルコール飲料、ジュース、炭
酸飲料等の飲料、砂糖菓子、パン製品、チューインガム
、衛生製品、化粧品、薬学および獣医学的調製品及びそ
れらの等価品を備えている。Products sweetened by the sweeteners of the present invention include all products in which a sweetening ingredient is desired, in particular foods for human or animal consumption, alcoholic beverages, non-alcoholic beverages, juices, beverages such as carbonated drinks, sugar confectionery. , bakery products, chewing gum, hygiene products, cosmetics, pharmaceutical and veterinary preparations and their equivalents.
本発明の甘味剤は、純度lOO%で化粧品等に添加して
甘みを加えることができる。しかし、本発明の甘味剤は
、高甘味度の性質から、最適な担体或は充填剤と混合し
て使用できる。この担体或は充填剤は、ポリデキストロ
ース、スターチ、マルトデキストリン、セルロース、メ
チルセルロース、カルボキシメチルセルロース、ハイド
ロオキンメチルセルロース、微品質セルロース、アルギ
ン酸ソータ、ヘクチン、ガム、ラクトース、マルトース
、クルコース、ロイシン、グリセロール、マニトール、
ソルビトール、炭酸水素ナトリウム、燐酸、クエン酸、
タルタル酸、ツマ−酸、安息香酸、ソルビン酸或はプロ
ピオン酸及びそれらのナトリウム、カリウム及びカルシ
ウム塩及び等何割からなる群から選択されることが好ま
しい。The sweetener of the present invention has a purity of 100% and can be added to cosmetics etc. to add sweetness. However, due to its high sweetness properties, the sweetener of the present invention can be used in combination with an optimal carrier or filler. The carrier or filler may be polydextrose, starch, maltodextrin, cellulose, methylcellulose, carboxymethylcellulose, hydroquine methylcellulose, fine cellulose, sorta alginate, hectin, gum, lactose, maltose, crucose, leucine, glycerol, mannitol. ,
Sorbitol, sodium bicarbonate, phosphoric acid, citric acid,
It is preferably selected from the group consisting of tartaric acid, thumaric acid, benzoic acid, sorbic acid or propionic acid and their sodium, potassium and calcium salts and their respective proportions.
本発明の甘味剤は、単独の甘味剤として、或は本発明の
甘味剤を二種以上混合して美容或は化粧製品に使用でさ
る。本発明の甘味剤は、砂糖(ショ糖)、コーンシロッ
プ、7ラクトース、せ味脱ペプチド誘導体(アスパラテ
ーム、アリテーム)、ジハイドロカルコーン、脱水イソ
マルトース、ステビオサイド、L−砂糖、グリシルリジ
ン、キリトール、ソルビトール、マニトール、アセサル
フ工−ムーに1サツカリン及びそれらのナトリウム、カ
リウム、アンモニウム及びカルシウム塩、シクラメン酸
及びそれらのナトリウム、カリウム、アンモニウム及び
カルシウム塩、トリクロロガラクトサクロース、モネリ
ン、タウマチン及び等価品のような他の甘味剤と併用で
きる。The sweetener of the present invention can be used as a single sweetener or as a mixture of two or more sweeteners of the present invention in beauty or cosmetic products. The sweetener of the present invention includes sugar (sucrose), corn syrup, 7-lactose, Semi depeptide derivatives (aspartame, alitame), dihydrochalcone, dehydrated isomaltose, stevioside, L-sugar, glycyrrhizine, kylitol, Sorbitol, mannitol, acesulfuric acid - such as sacchulin and their sodium, potassium, ammonium and calcium salts, cyclamenic acid and their sodium, potassium, ammonium and calcium salts, trichlorogalactosacrose, monellin, thaumatin and equivalents. Can be used in combination with other sweeteners.
本発明の甘味剤の調製方法は、要望される甘味剤の一般
式において、Aが0、S、NH或はNCNかに依存して
変化している。The method of preparing the sweetener of the present invention varies depending on whether A is 0, S, NH or NCN in the general formula of the desired sweetener.
調製方法は以下の縮合反応を備えている。The preparation method comprises the following condensation reaction.
(1) RNH2及びA = C= N−(CHz)
、−BAがOの時には、反応が室温或は沸騰温度でアセ
トリトリル或はクロロホルムのような有機溶媒内で実施
される。(1) RNH2 and A = C = N-(CHz)
, -BA is O, the reaction is carried out in an organic solvent such as acetotrile or chloroform at room temperature or boiling temperature.
(2)R−N=C=A及び
H2N −(CH2)−−C00H
Aが0或はSの時には、反応が室温の水内で実施され、
R−N=C=Aがベンゼン或はクロロベンゼンのような
有機溶媒に溶解する。(2) R-N=C=A and H2N-(CH2)--C00H When A is 0 or S, the reaction is carried out in water at room temperature,
R-N=C=A dissolves in organic solvents such as benzene or chlorobenzene.
(3) R−NH−C3−NH2及びH!N −(C
Hz)−−B 。(3) R-NH-C3-NH2 and H! N-(C
Hz)--B.
AがNHの時、或は
RNHC3−NH(CH2)−B
及びNH,或は
RNHC9NH(CHz)、 B
及びH2N CN
AがNCNの時には、反応がジシクロへキシルカルボジ
イミドのような縮合剤の存在下で室温或は沸騰温度で有
効となる。When A is NH, or RNHC3-NH(CH2)-B and NH, or RNHC9NH(CHz), B and H2N CN When A is NCN, the reaction is carried out in the presence of a condensing agent such as dicyclohexylcarbodiimide. Effective at room temperature or boiling temperature.
(4)R−NH=CCIl−NH−(CH,)、−B及
びNH。(4) R-NH=CCIl-NH-(CH,), -B and NH.
AかNHの時には、R−NH−CCII−NH(CH2
)、−Bが室温でクロロホルム或は酢酸エチル内におけ
るR−N=CCQ2とH2N −(CH2)、 Bの
縮合で得られ、反応混合物がNH。When A or NH, R-NH-CCII-NH(CH2
), -B is obtained by condensation of RN=CCQ2 and H2N -(CH2), B in chloroform or ethyl acetate at room temperature, and the reaction mixture is NH.
との縮合用に70℃に加熱された。was heated to 70°C for condensation with
(5) R−NH−C(=A)−5CH,及びH2N
−(CH2)、−COOH
AがNH或はNCNの時には、反応がNaOH或はN
(C:Hs)i等の塩基の存在下でエタノール/水混合
液内で沸騰温度で実施された。(5) R-NH-C(=A)-5CH, and H2N
-(CH2), -COOH When A is NH or NCN, the reaction is NaOH or NCN.
It was carried out in an ethanol/water mixture at boiling temperature in the presence of a base such as (C:Hs)i.
(6)R=NH−C(−NCN)−NH−(CH,)。(6) R=NH-C(-NCN)-NH-(CH,).
B及び塩酸水溶液 AがNHの時には、加水分解が70°Cで実施された。B and aqueous hydrochloric acid solution When A was NH, hydrolysis was carried out at 70°C.
使用された薬剤の一般式においては、R及びnが前述の
定義を適応し、Bが例えばメチル、エチル、三級ブチル
、ベンジルエステル等のエステル形態の保護されたカル
ボキル基に相当し、保護基が例えばNaOHによる酸化
或は塩酸による加水分解等の最適な手段によって除去さ
れる。In the general formula of the drug used, R and n apply the above definitions, B corresponds to a protected carboxyl group, for example in the form of an ester such as methyl, ethyl, tertiary butyl, benzyl ester, etc. is removed by suitable means such as oxidation with NaOH or hydrolysis with hydrochloric acid.
本発明の合成物を得るために、第1〜第6方法は、各方
法に特定される実験的条件及びnの値及びA、R及びB
の特性関数として当業者によって選択できる。In order to obtain the compounds of the present invention, the first to sixth methods are carried out using the experimental conditions and values of n and A, R and B specified for each method.
can be selected by a person skilled in the art as a characteristic function of .
本発明の合成物は、酸或はアルカリ(塩)の状態で存在
できる。従って、これら合成物は、生理学的に許容でき
る無機或は有機塩基によってアルカリ、或はAがNHで
ある時に生理学的に許容できる無機或は有機酸に変換で
きる。これらの塩を調製する種々の方法の1つは、本発
明の合成物及び−等酒塩或は無期成は有機酸の水溶混合
液を真空下で乾燥状態に濃縮することからなっている。The compositions of the invention can exist in acid or alkali (salt) form. These compounds can therefore be converted to alkalis by physiologically acceptable inorganic or organic bases, or to physiologically acceptable inorganic or organic acids when A is NH. One of the various methods of preparing these salts consists of concentrating an aqueous mixture of the compounds of the invention and the alcoholic salts or organic acids to dryness under vacuum.
本発明の好ましい塩は、ナトリウム、アンモニウム、カ
ルンウム及びマグネンウム塩であり、或はAがNHの場
合に塩化物である。Preferred salts of the invention are sodium, ammonium, carunium and magnenium salts, or chloride when A is NH.
本発明の合成物の精製は、再結晶、クロマトグラフィ等
の標準技術によって実現できる。これらの純度及び構造
は、薄膜クロマトグラフィ、高性能液体クロマトグラフ
ィ、赤外分光計、核磁気共鳴及び要素分析のような従来
の技術によって検査できる。Purification of the compounds of the invention can be accomplished by standard techniques such as recrystallization, chromatography, etc. Their purity and structure can be tested by conventional techniques such as thin film chromatography, high performance liquid chromatography, infrared spectroscopy, nuclear magnetic resonance and elemental analysis.
かく調製された合成物の甘味度は、8人の経験豊かな検
査人のグループによって評価された。この目的のために
、種々の濃度の合成物の水溶液は、甘味度が、普通の用
途に対応する濃度、即ち2%、ある場合において5%及
び10%の濃度のショ糖の標準溶液と比較された。実際
、合成甘味剤の甘味度が参照用として使用されたショ糖
溶液の濃度の関数として変化する。従って、ショ糖と比
較して検査された合成物の甘味度は、同じ甘味強度の合
成物及びショ糖間で存在する重量比に対応し、即ち検査
される合成物の溶液及び標準ショ糖溶液の甘味検査が同
じ甘味強度を持つと言う検査人の多数決によって考慮さ
れた。The sweetness of the composition thus prepared was evaluated by a group of 8 experienced testers. For this purpose, aqueous solutions of the compound at various concentrations are compared in sweetness with standard solutions of sucrose at concentrations corresponding to common uses, namely 2%, and in some cases 5% and 10%. It was done. Indeed, the sweetness of synthetic sweeteners varies as a function of the concentration of the sucrose solution used as a reference. Therefore, the sweetness of the compound tested compared to sucrose corresponds to the weight ratio existing between the compound and sucrose of the same sweetness intensity, i.e. the solution of the compound tested and the standard sucrose solution. sweetness tests were considered by a majority vote of the testers as having the same sweetness intensity.
本発明の甘味剤は、甘味を加えることが望ましい美容或
は化粧製品に、所望レベルの甘みを加えることに十分な
比率で添加できることの利点を持っている。この甘味剤
の最適な用途濃度は、例えば甘味剤の甘味度、貯蔵状態
、食品の種類、製品の特定成分、美容製品の芳香度及び
甘みの所望レベル等の種々の因子に依存する。当該分野
の技術者は、繰り返しの味覚分析の実施によって、美容
製品を得るために用いられなければならない甘味剤の最
適な比率を容易に決定できる。本発明の好ましい甘味剤
は、通常美容製品の約0.QO1〜約1〜02重量%の
比率で美容製品に添加される。The sweeteners of the present invention have the advantage that they can be added to beauty or cosmetic products in which sweetening is desired in proportions sufficient to provide the desired level of sweetness. The optimum application concentration of the sweetener depends on a variety of factors, such as the sweetness of the sweetener, storage conditions, type of food product, specific ingredients of the product, aromaticity of the beauty product, and desired level of sweetness. A person skilled in the art can easily determine the optimal ratio of sweeteners that must be used to obtain a beauty product by performing repeated taste analyses. Preferred sweeteners of the present invention are typically found in beauty products at about 0. It is added to beauty products in proportions from QO1 to about 1-02% by weight.
明らかに、濃縮物は、より高百分率の甘味剤を含んで、
その後極端な使用目的に従って希釈できるであろう。Obviously, concentrates contain a higher percentage of sweeteners,
It could then be diluted according to the extreme intended use.
本発明の甘味剤の非常に重要な利点は、多くの場合にお
いて、例えばグリシルヒジン或はタウマチンのような甘
草の後味を持たないで、例えばサッカリン或はアセスル
ファームにのような金属性或は苦い後味を伴わないで、
ショ糖のそれと非常に似た甘味を形成することである。A very important advantage of the sweeteners of the invention is that in many cases they do not have a licorice aftertaste, such as glycyrrhizin or thaumatin, but have a metallic or bitter taste, such as saccharin or acesulfame. without aftertaste,
It forms a sweet taste very similar to that of sucrose.
本発明に記載された複素即ち異種環式誘導体は、従来技
術(lLebensm、Unlers、Forsch、
1982年175.266〜268頁参照)及び米国
特許出願第836,071号に記載された炭素環式類似
物のそれに匹敵する酸の状態下で一安定性を明確に持っ
ているが、既に述べたように、同じ状態下でこれら文献
に成功裏に示した溶解度より更に水に溶は得る溶解度を
持つ利点を有している。The heterocyclic or heterocyclic derivatives described in the present invention are based on the prior art (Lebensm, Unlers, Forsch,
1982, pp. 175, 266-268) and U.S. Patent Application Ser. As mentioned above, it has the advantage of having a solubility that is even more soluble in water than that successfully demonstrated in these documents under the same conditions.
溶解度は次の方法で測定された。溶解度が決定されるべ
き過剰の合成物は、炭酸飲料の調製及び貯蔵温度に対応
する0℃近傍の温度条件において、燐酸緩衝液でpH3
に調製された水の分散液に追加された。この分散液は、
氷温槽に載せられ、その後60分間超音波撹拌され、そ
の後、0.45ミクロンのミリポア ミレックスーHV
フィルタ(Millipore Millex−■
V)を通して濾過された。Solubility was measured by the following method. The excess compound whose solubility is to be determined is diluted to pH 3 with phosphate buffer at temperature conditions around 0°C, corresponding to the preparation and storage temperature of carbonated beverages.
was added to the water dispersion prepared. This dispersion is
placed in an ice bath, then ultrasonically agitated for 60 minutes, and then 0.45 micron Millipore Millex-HV
Filter (Millipore Millex-■
V).
結果として、濾過液に飽和溶解した合成物が高性能液体
クロマトグラフィによって、公知の濃度の標準溶液に相
対して決定された。As a result, the saturated solution of the compound in the filtrate was determined by high performance liquid chromatography relative to a standard solution of known concentration.
この方法において、例えば、成分Rが2−シアノピリド
−5−ニルである本発明の第4実施例に記載された合成
物はOoCで約400111!/リツトルの溶解度を持
っているが、2. Lcbe++sm、 Unters
。In this method, for example, the compound described in the fourth example of the invention, in which component R is 2-cyanopyrid-5-yl, has an OoC of about 400111! /liter, but 2. Lcbe++sm, Unters
.
Forsch、の第16実施例に記載の4−シアノフェ
ニル炭素環式類似物が同じ条件下で約100mg/リン
ドルの溶解度しか持っていす、従って複素環式誘導体の
溶解度がそれの炭素環式類似物のそれより約4倍である
ことが観測された。同様に、例えば、成分Rが5−ベン
ゾフラザニル基である本発明の第1O実施例に記載され
た合成物は0°Cで約1150mg/リットルの溶解度
を持ち、従って、約410m(/’Jットルの溶解度を
持つ米国特許比fimg36.o7を号の第3実施例に
記載の4ンアノフ工ニル炭素環式合成物のそれより約2
゜8倍であることが観測された。Forsch, the 4-cyanophenyl carbocyclic analog described in Example 16 has a solubility of only about 100 mg/lindole under the same conditions, thus the solubility of the heterocyclic derivative is lower than that of its carbocyclic analog. It was observed that it is about 4 times as large as that of . Similarly, for example, the compound described in the first embodiment of the invention, in which component R is a 5-benzofurazanyl group, has a solubility of about 1150 mg/liter at 0°C, and thus about 410 m(/'J Torr). The U.S. patent ratio fimg36.o7 with a solubility of about 2
It was observed that it was 8 times as large.
「実施例」 以下に実施例を参照して本発明が説明する。"Example" The invention will be explained below with reference to examples.
第1実施例
4−ピリジルカルバモイル−β−アラニンの合成
1グラム(10,64ミリモル)の4−アミノピリジン
及び2.3グラム(15,9ミリモル)のβ−アラニン
エチルエステル イソシアネートの溶液は、30rA
Qの無水アセトニトリルに入れられて室温で20時間撹
拌された。その後乾燥状態まで濃縮し、結果の油性残余
を50m1lのエーテル内で粉砕した後、2.5グラム
(収率88%)の4−ピリジルカルバモイル−β−アラ
ニン エチノしエステルが95°Cの融点を有する固体
として得られた。First Example Synthesis of 4-pyridylcarbamoyl-β-alanine A solution of 1 gram (10,64 mmol) of 4-aminopyridine and 2.3 grams (15,9 mmol) of β-alanine ethyl ester isocyanate was prepared at 30 rA
Q of anhydrous acetonitrile and stirred at room temperature for 20 hours. After concentrating to dryness and trituring the resulting oily residue in 50 ml of ether, 2.5 g (88% yield) of 4-pyridylcarbamoyl-β-alanine ethinoester was obtained with a melting point of 95°C. Obtained as a solid with
2グラム(8,4ミリモル)の4−ピリジルカルバモイ
ル−β−アラニン エチルエステル及び0゜37グラム
(9,2ミリモル)の水酸化ナトリウムは、50all
のメタノール及び0.1mMの水内に移され室温で24
時間撹拌された。乾燥状態まで濃濃縮された後結果の油
性残余が15mAの水に移された。10m1lのジクロ
ロメタンで3回洗浄後、水溶液相は3Nの塩酸溶液によ
ってpH3が得られるまで酸性化された。生成された沈
澱物は、濾過され、1OIIIAの冷水によって洗浄さ
れ、その後乾燥された。この結果、1.36グラム(収
率95%)の4−ピリジルカルバモイル−β−アラニン
が222°C融点を有する固体として得られた。2 grams (8,4 mmol) of 4-pyridylcarbamoyl-β-alanine ethyl ester and 0.37 grams (9,2 mmol) of sodium hydroxide are
of methanol and 0.1 mM water at room temperature for 24 hours.
Stirred for an hour. After being concentrated to dryness, the resulting oily residue was transferred to 15 mA water. After washing three times with 10 ml of dichloromethane, the aqueous phase was acidified with 3N hydrochloric acid solution until a pH of 3 was obtained. The precipitate formed was filtered, washed with 1 OIIIA of cold water, and then dried. This resulted in 1.36 grams (95% yield) of 4-pyridylcarbamoyl-β-alanine as a solid with a melting point of 222°C.
この合成物は、糖度が重量基準で2%ショ糖溶液と比較
して、ンヨ糖のそれの約50倍に対応していた。The sugar content of this compound corresponded to about 50 times that of sucrose compared to a 2% sucrose solution on a weight basis.
第2実施例
2−クロロ−5−ピリジルカルバモイル−βアラニンの
合成
25mQのベンゼンに溶解した2グラム(i2゜9ミリ
モル)の2−クロロ−5−ピリジル イソシモル)のβ
−アラニン及び0.75グラム(7ミリモル)の炭酸ナ
トリウムを含有する25mAの水溶液に加えられた。こ
の溶液は、室温で1時間激しく撹拌された後に、50m
Aのエチルエーテルで3回抽出された。液相は、冷却さ
れ、その後3Nの塩酸溶液で約3のpHが得られるまで
酸性化された。生成された沈澱物は、濾過され、10m
11の冷水で洗浄され、その後乾燥された。この結果、
1゜5グラム(収率45%)の2−クロロ−5−ピリジ
ルカルバモイル−β−アラニンが200℃融点を有する
固体形態で得られた。Second Example Synthesis of 2-chloro-5-pyridylcarbamoyl-β-alanine 2 grams (i2°9 mmol) of β-2-chloro-5-pyridyl isosymol) dissolved in 25 mQ of benzene
- added to a 25 mA aqueous solution containing alanine and 0.75 grams (7 mmol) of sodium carbonate. This solution was stirred vigorously for 1 hour at room temperature, then 50 m
A was extracted three times with ethyl ether. The liquid phase was cooled and then acidified with 3N hydrochloric acid solution until a pH of approximately 3 was obtained. The generated precipitate was filtered and 10 m
11 of cold water and then dried. As a result,
1.5 grams (45% yield) of 2-chloro-5-pyridylcarbamoyl-β-alanine was obtained in solid form with a melting point of 200°C.
この合成物は、糖度が重量基準で2%ショ糖溶液と比較
して、ショ糖のそれの約50倍に対応していた。The sugar content of this compound corresponded to about 50 times that of sucrose compared to a 2% sucrose solution on a weight basis.
第3実施例
N−[2−クロロ−5−アミノピリジル(イミノ)メチ
ル]−2−アミノ酢酸の合成
アネートの溶液は、1.26グラム(14,2ミリ1.
2グラム(6,4ミリモル)の2−クロロ−5−アミノ
ピリジルチオ尿素、1グラム(7,68ミリモル)のグ
リシン三級ブチルエステル及び1.45グラム(7,0
4ミリモル)のジシクロへキシルカルボジイミドの溶液
は、30m1の酢酸エチルに加えられ、60°Cで2.
5時間加熱された。生成したジシクロへキシルチオ尿素
沈澱物は濾過によって除去された。上澄みは乾燥状態ま
で濃縮され、得られた生成物が20mQのジクロロメタ
ンに移され、その後0.25Nの希塩酸溶液(4X 3
0m1)で抽出された。この酸性溶液は、その後INの
水酸化ナトリウムで中和され、その後ジクロロメタン(
3x 20m1)によって抽出され、従って、油状形態
の三級ブチル−N−[2−り四ロー5−アミノピリジル
(イミノ)メチル] −2−アミノ酢酸が0.65グラ
ム(収率36%)得られた。Third Example Synthesis of N-[2-chloro-5-aminopyridyl(imino)methyl]-2-aminoacetic acid A solution of 1.26 grams (14.2 milliliters.
2 grams (6,4 mmol) of 2-chloro-5-aminopyridylthiourea, 1 gram (7,68 mmol) of glycine tertiary butyl ester and 1.45 grams (7,0
A solution of dicyclohexylcarbodiimide (4 mmol) was added to 30 ml of ethyl acetate and heated at 60°C for 2.
Heated for 5 hours. The dicyclohexylthiourea precipitate formed was removed by filtration. The supernatant was concentrated to dryness and the resulting product was transferred to 20 mQ dichloromethane, followed by 0.25N dilute hydrochloric acid solution (4X 3
0ml). This acidic solution was then neutralized with IN sodium hydroxide followed by dichloromethane (
3x 20 ml), thus obtaining 0.65 g (36% yield) of tert-butyl-N-[2-lytetra-5-aminopyridyl(imino)methyl]-2-aminoacetic acid in oily form. It was done.
かく生成されたエステル0.65グラム(2,3ミリモ
ル)は、1.5mQの氷酢酸及びジオキサンに7規定加
えた塩酸溶液3.2 mQ(2,3ミリモル)内に溶解
させた。室温で1.5時間後、溶媒が減圧下で除去され
た。残余がエチルエステル(4×20 ml)内に移さ
れ、その後15m(の飽和炭酸ナトリウム水溶液に溶解
させた。10mQのジクロロメタンで3回洗浄後、液相
は3Nの塩酸溶液によってp H4になるまで酸性化さ
れた。生成された沈澱物は、濾過され、5mQの冷水に
よって洗浄され、その後乾燥された。この結果、0.1
1グラム(収率21%)のN−[2−クロロ−5−アミ
ノピリジル(イミノ)メチル] −2−アミノ酢酸が2
40°C融点を有する固体形態で得られた。0.65 grams (2.3 mmol) of the ester thus produced were dissolved in 3.2 mQ (2.3 mmol) of a 7N hydrochloric acid solution in 1.5 mQ glacial acetic acid and dioxane. After 1.5 hours at room temperature, the solvent was removed under reduced pressure. The residue was transferred into ethyl ester (4 x 20 ml) and then dissolved in 15 mQ of saturated aqueous sodium carbonate. After washing three times with 10 mQ of dichloromethane, the liquid phase was brought to pH 4 with 3N hydrochloric acid solution. The precipitate formed was filtered, washed with 5 mQ of cold water and then dried. This resulted in a concentration of 0.1
1 gram (21% yield) of N-[2-chloro-5-aminopyridyl(imino)methyl]-2-aminoacetic acid
Obtained in solid form with a melting point of 40°C.
この合成物は、糖度が重量基準で2%ショ糖溶液と比較
して、ショ糖のそれの約50倍に対応していた。The sugar content of this compound corresponded to about 50 times that of sucrose compared to a 2% sucrose solution on a weight basis.
第4実施例
2−シアノ−5−ピリジルカルバモイル−β−アラニン
の合成
この合成物は、第2実施例に記載された実験手順に従っ
て、β−アラニンからの一水塩物及び2シアノ−5−ピ
リジル イソシアネートから得られた(収率24%、1
73℃の融点)。Fourth Example 2 - Synthesis of Cyano-5-pyridylcarbamoyl-β-alanine This compound was synthesized from β-alanine monohydrate and 2-cyano-5-alanine according to the experimental procedure described in Example 2. Obtained from pyridyl isocyanate (yield 24%, 1
melting point of 73°C).
この合成物は、糖度が重量基準で2%ショ糖溶液と比較
して、ショ糖のそれの約700倍に対応していた。This compound had a sugar content corresponding to approximately 700 times that of sucrose compared to a 2% sucrose solution on a weight basis.
第5実施例
2−シアノ−5−ピリミジニルカルバモイル)−β−ア
ラニンの合成
0.83グラム(7ミリモル)の2−シアノ−5−アミ
ノピリミジン及び1グラム(7ミリモル)のβ−アラニ
ン
エチルエステル イソシアネート
の溶液は、30m11の無水アセトニトリルに加えられ
て70℃で4時間加熱された。この反応混合物は、乾燥
状態まで濃縮され、0.INの塩酸50mCによって7
0°C3時間かけて直接加水分解され、冷却後、p H
が10になるまで水酸化ナトリウムで処理され、3×4
0mMのジクロロメタンで洗浄され、塩酸でpHが3に
なるまで酸性化され、その後真空内で乾燥状態まで濃縮
された。この残余は、純度lOO%の絶対エタノールに
よる処理、乾燥状態までエタノール抽出の濃縮によって
、0゜74グラム(収率45%)の2−シアノ−5−ピ
リミジニルカルバモイル)−β−アラニンが183°C
の融点を有する固体の形態で得られた。Example 5 Synthesis of 2-cyano-5-pyrimidinylcarbamoyl)-β-alanine 0.83 grams (7 mmol) of 2-cyano-5-aminopyrimidine and 1 gram (7 mmol) of β-alanine ethyl ester isocyanate The solution was added to 30ml of anhydrous acetonitrile and heated at 70°C for 4 hours. The reaction mixture was concentrated to dryness and 0% 7 by 50 mC of hydrochloric acid in
It is directly hydrolyzed at 0°C for 3 hours, and after cooling, the pH
treated with sodium hydroxide until 10, 3×4
Washed with 0 mM dichloromethane, acidified with hydrochloric acid to pH 3, then concentrated to dryness in vacuo. This residue was purified by treatment with absolute ethanol of 100% purity and concentration of ethanol extraction to dryness to yield 0.74 grams (45% yield) of 2-cyano-5-pyrimidinylcarbamoyl)-β-alanine at 183°C.
It was obtained in the form of a solid with a melting point of .
この合成物は、糖度が重量基準で2%ショ糖溶液と比較
して、ショ糖のそれの約400倍に対応していた。The sugar content of this compound corresponded to about 400 times that of sucrose compared to a 2% sucrose solution on a weight basis.
第6実施例
2−シアノ−5−ピリミジニルチオカルバモイル−β−
アラニンの合成
この合成物は、第2実施例に記載された実験手順に従っ
て、β−アラニン及び2−シアノ−5−ピリジニル イ
ソチ第2ンア不一トから得られた(収率13%、135
°Cの融点)。Sixth Example 2-Cyano-5-pyrimidinylthiocarbamoyl-β-
Synthesis of Alanine This compound was obtained from β-alanine and 2-cyano-5-pyridinyl isothyenatrimonoxide (yield 13%, 135
melting point in °C).
この合成物は、糖度が重量基準で、2%ショ糖溶液と比
較して、ショ糖のそれの約1000倍に対応していた。This compound had a sugar content, on a weight basis, corresponding to approximately 1000 times that of sucrose compared to a 2% sucrose solution.
第7実施例
5−ベンゾフラザニルカルバモイル グリシンの合成
この合成物は、第2実施例に記載された実験手順に従っ
て、グリシン及び5−ベンゾフラザニルイソシアネート
から得られた(収率68%、212°Cの融点)。Seventh Example 5 - Synthesis of Benzofurazanyl Carbamoyl Glycine This compound was obtained from glycine and 5-benzofurazanyl isocyanate (68% yield, 212 melting point in °C).
この合成物は、糖度が重量基準で、2%ショ糖溶液と比
較して、ショ糖のそれの約20倍に対応していた。The sugar content of this compound corresponded to about 20 times that of sucrose on a weight basis compared to a 2% sucrose solution.
第8実施例
5−ベンゾフラザニルカルバモイル−β−アラニンの合
成
この合成物は、第2実施例に記載された実験手順に従っ
て、β−アラニン及び5−ベンゾフラザニル イソシア
ネートから得られた(収率47%、208°Cの融点)
。Example 8 Synthesis of 5-Benzofurazanylcarbamoyl-β-alanine This compound was obtained from β-alanine and 5-benzofurazanyl isocyanate (47% yield) following the experimental procedure described in Example 2. , melting point of 208°C)
.
この合成物は、糖度が重量基準で、2%ショ糖溶液と比
較して、ショ糖のそれの約800倍に対応していた。This compound had a sugar content, on a weight basis, corresponding to approximately 800 times that of sucrose compared to a 2% sucrose solution.
第9実施例
N−[5−ベンゾ7ラザニルアミノ(イミノ)メチル]
−2−アミン酢酸の合成
この合成物は、第3実施例に記載された実験手順に従っ
て、5−ベンゾフラザニルチオ尿素及びグリシン三級ブ
チルエステルから得られた(収率25%、181°Cの
融点)。9th Example N-[5-benzo7lazanylamino(imino)methyl]
-Synthesis of 2-Amine Acetic Acid This compound was obtained from 5-benzofurazanylthiourea and glycine tertiary butyl ester (25% yield, 181 °C melting point).
この合成物は、糖度が重量基準で、2%ショ糖溶液と比
較して、ショ糖のそれの約200倍に対応していた。The sugar content of this compound corresponded to about 200 times that of sucrose on a weight basis compared to a 2% sucrose solution.
第10実施例
N−[シアノイミノ(5−ベンゾフラザニルアミノ)メ
チル]−3−アミノプロピオン酸の合成1.3グラム(
4,4ミリモル)の5−ベンゾ7ラザニルチオカルバモ
イルー
エステル、0.371グラム(8.8ミリモル)のシア
ナミド、1.36グラム(6、6ミリモル)のジシクロ
へキシルカルボジイミド及び0 、 1 mlIのトリ
エチルアミンの溶液は、30mlの無水アセトニトリル
内で室温で40時間放置された。この混合物は、乾燥状
態まで濃縮され、この結果、油性成分がエチルエステル
(3 X 3 0ml)内で粉砕されて、1グラム(収
率76%)の固体が得られた。この固体は、C H C
113/アセトンの流量比が90/10であるシリカ
カラム上で精製された後、155°Cの融点を持つエチ
ル−N−[シアノイミノ(5ベンゾフラザニルアミノ)
メチル]ー3ーアミノプロピオン酸0.5グラムが得ら
れた。Example 10 Synthesis of N-[cyanoimino(5-benzofurazanylamino)methyl]-3-aminopropionic acid 1.3 grams (
4,4 mmol) of 5-benzo7lazanylthiocarbamoyl ester, 0.371 grams (8.8 mmol) of cyanamide, 1.36 grams (6,6 mmol) of dicyclohexylcarbodiimide and 0.1 ml I A solution of triethylamine was left in 30 ml of anhydrous acetonitrile at room temperature for 40 hours. The mixture was concentrated to dryness so that the oily component was triturated in ethyl ester (3 x 30 ml) to give 1 gram (76% yield) of a solid. This solid is C H C
Ethyl-N-[cyanoimino(5benzofurazanylamino) with a melting point of 155 °C after being purified on a silica column with a flow ratio of 113/acetone of 90/10.
0.5 g of methyl]-3-aminopropionic acid was obtained.
かく得られた0.5グラム(1 、6 5ミリモル)の
エステル及び0.066グラム(1 、6 5ミリモル
)の水酸化ナトリウムは、15+1111のメタノール
及び0、1mQの水に加えられて室温で30時間放置さ
れた。この混合物は乾燥状態まで濃縮され、得られた残
余にlOrR1!の水が加えられ、残余がジクロロメタ
ン(3X20I+11)で洗浄されて精製された。0.5 g (1.65 mmol) of the ester and 0.066 g (1.65 mmol) of sodium hydroxide thus obtained were added to 15+1111 methanol and 0.1 mQ of water at room temperature. It was left for 30 hours. This mixture is concentrated to dryness and the resulting residue is lOrR1! of water was added and the residue was purified by washing with dichloromethane (3X20I+11).
この結果、冷却されだ液相には、pi(が3になるまで
3Nの塩酸溶液が加えられて酸性化された。As a result, the cooled liquid phase was acidified by adding 3N hydrochloric acid solution until pi() became 3.
かく得られた固体は、濾過によって回収されて、その後
2X3mllの水で洗浄された。乾燥後、0。The solid thus obtained was collected by filtration and then washed with 2×3 ml of water. After drying, 0.
2グラム(収率44%)のN−[シアノイミノ (5ベ
ンゾフラザニルアミノ)メチル] −3−アミノフロピ
オン酸(融点92℃)が得られた。2 grams (44% yield) of N-[cyanoimino(5benzofurazanylamino)methyl]-3-aminoflopionic acid (melting point 92°C) were obtained.
この合成物は、糖度が重量基準で、2%ショ糖溶液と比
較して、ショ糖のそれの約200倍に対応していた。The sugar content of this compound corresponded to about 200 times that of sucrose on a weight basis compared to a 2% sucrose solution.
第11実施例
1−才キサイド−5−ベンゾフラザニルカルバモイル−
β−アラニンの合成
この合成物は、第2実施例に記載された実験手順に従っ
て、β−アラニン及び1−才キサイド−5−ベンゾ7ラ
ザニル イソシアネートから得られた(収率76%、1
96°Cの融点)。11th Example 1 - Oxide-5-benzofurazanylcarbamoyl-
Synthesis of β-Alanine This compound was obtained from β-alanine and 1-year-old oxide-5-benzo7 lazanyl isocyanate (76% yield, 1
melting point of 96°C).
この合成物は、糖度が重量基準で、2%ショ糖溶液と比
較して、ンEI塘のそれの約500倍に対応していた。This compound had a sugar content, on a weight basis, corresponding to approximately 500 times that of NEI Tong compared to a 2% sucrose solution.
第12実施例
5−ベンゾチオフラザニルカルバモイル−β−アラニン
の合成
この合成物は、第2実施例に記載された実験手順に従っ
て、β−アラニン及び5−ベンゾチオ7ラザニル イソ
シアネートから得られた(収率47%、189°Cの融
点)。Example 12 Synthesis of 5-Benzothiofurazanylcarbamoyl-β-alanine This compound was obtained from β-alanine and 5-benzothio7lazanyl isocyanate (harvested) according to the experimental procedure described in Example 2. 47%, melting point of 189°C).
この合成物は、糖度が重量基準で、2%ショ糖溶液と比
較して、ショ糖のそれの約50倍に対応していた。The sugar content of this compound corresponded to about 50 times that of sucrose on a weight basis compared to a 2% sucrose solution.
第13実施例
(IH−インダシルー6−、ニル)チオカルバモイル−
β−アラニンの合成
5グラム(28,6ミリモル)のIH−インダシルー6
−ニルーインチオシアネート、5.3グラム(34,3
ミリモル)のβ−アラニン エチルエステル塩酸溶液及
び4.8 mff1(34,3ミリモル)のトリエチル
アミンの溶液は、50mQのクロロホルム内で撹拌しな
がら1時間室温で放置された。クロロホルム液相が水(
2x 10mA)及びIN塩酸溶液(2x 10mn)
で洗浄された。その後、乾燥状態まで濃縮された。この
残余(8グラム)はエチルエステル(3x20ml+)
内で粉砕されて、145°Cの融点を持つ3.1グラム
(収率28%)の(IH−インダゾル−6−ニル)チオ
カルバモイル−βアラニン エチルエステルが得られた
。Example 13 (IH-Indacyl-6-,Nyl)thiocarbamoyl-
Synthesis of β-alanine 5 grams (28,6 mmol) of IH-Indacylu6
- Niluinthiocyanate, 5.3 grams (34,3
A solution of β-alanine ethyl ester hydrochloride (1 mmol) and 4.8 mff1 (34.3 mmol) of triethylamine was left at room temperature for 1 hour with stirring in 50 mQ chloroform. The chloroform liquid phase is water (
2x 10mA) and IN hydrochloric acid solution (2x 10mn)
was washed with It was then concentrated to dryness. The remainder (8 grams) is the ethyl ester (3x20ml+)
3.1 grams (28% yield) of (IH-indazol-6-yl)thiocarbamoyl-β-alanine ethyl ester with a melting point of 145°C was obtained.
かく得られた0、6グラム(2,05ミリモル)のエス
テル及び0.09グラム(2,36ミリモル)の水酸化
ナトリウムは、15+++Ilのメタノール及び0゜1
mlの水内に加えられて、室温で20時間撹拌しながら
放置された。乾燥状態まで濃縮後、得られた残余には1
0m1の水が加えられた。この残余が酢酸エチル(3X
20mM)による抽出によって精製された後、生成され
だ液相は、冷却され、その後、pHが3になるまで3N
の塩酸溶液によって酸性化された。従って、0.293
グラム(収率56%)の(LH−インダシルー6−ニル
)チオカルバモイル−β−アラニンは、175°Cの融
点を持つ固体として得られた。0.6 g (2.05 mmol) of ester and 0.09 g (2.36 mmol) of sodium hydroxide thus obtained were mixed with 15+++ Il of methanol and 0.1
ml of water and left with stirring at room temperature for 20 hours. After concentrating to dryness, the resulting residue contains 1
0ml of water was added. This residue is ethyl acetate (3X
After purification by extraction with 20mM), the resulting liquid phase is cooled and then diluted with 3N until the pH is 3.
acidified by a hydrochloric acid solution. Therefore, 0.293
(56% yield) of (LH-indasy-6-yl)thiocarbamoyl-β-alanine was obtained as a solid with a melting point of 175°C.
この合成物は、糖度が重量基準で、2%ショ糖溶液と比
較して、ショ糖のそれの約150倍に対応していた。The sugar content of this compound corresponded to about 150 times that of sucrose on a weight basis compared to a 2% sucrose solution.
第1〜第13実施例に示された種々の合成物の甘味度は
、次の第1表に要約されている。甘味度は、重量基準で
、2%ショ糖溶液と比較して評価されている。The sweetness levels of the various compositions shown in Examples 1-13 are summarized in Table 1 below. Sweetness is evaluated on a weight basis compared to a 2% sucrose solution.
第 ■ 表 R−NH−C−NH−(CH,)。No. ■ table R-NH-C-NH-(CH,).
OOH 合成物 甘味度OOH compound sweetness level
Claims (6)
あり、 前記単環式基が以下の群から選択され、 ▲数式、化学式、表等があります▼ 但し、Xは、Cl、CN或はNO_2基であり、▲数式
、化学式、表等があります▼ 但し、G_1がCH或はNであり、 G_2がCH_2、CO、NH、NCH_3、O或はS
であり、 G_3及びG_4がCH、CCH_3、N或はNOであ
り、前記Aは、O、S、NH或はN−CNで、NHが塩
酸塩形態に塩化され、 前記nは、1或は2であり、 前記Bは、COOH或はナトリウム、カリウム、アンモ
ニウム、カルシウム或はマグネシウム塩である複素環式
基を持つ甘味剤。(1) It has the following general formula, ▲There are mathematical formulas, chemical formulas, tables, etc.▼ However, the above R is a monocyclic or bicyclic heterocyclic group, and the above monocyclic group is the following: ▲There are mathematical formulas, chemical formulas, tables, etc.▼ However, X is Cl, CN, or NO_2 group, ▲There are mathematical formulas, chemical formulas, tables, etc.▼ However, if G_1 is CH or N Yes, G_2 is CH_2, CO, NH, NCH_3, O or S
, G_3 and G_4 are CH, CCH_3, N or NO, the A is O, S, NH or N-CN, NH is chlorinated in the form of hydrochloride, and the n is 1 or 2, wherein B is a sweetener having a heterocyclic group which is COOH or a sodium, potassium, ammonium, calcium or magnesium salt.
−シアノピリミジン−5−ニル基であり、前記AがO或
はNHであり、 前記nは、AがNHである時に1、或はAがOである時
に2である特許請求の範囲第1項記載の甘味剤。(2) The above R is a 2-cyanopyrid-5-nyl group or a 2-cyanopyrid-5-yl group
-cyanopyrimidin-5-yl group, and the A is O or NH, and the n is 1 when A is NH, or 2 when A is O. Sweeteners listed in section.
甘味剤の適量が添加される甘味食品、飲料、キャンデ、
パン菓子、チューインガム、衛生製品、化粧品、化粧備
品、薬学および獣医学的調製品等の甘味方法。(3) Sweet foods, beverages, and candy to which an appropriate amount of at least one sweetener according to claim 1 is added;
Sweetening methods for pastries, chewing gum, hygiene products, cosmetics, toiletries, pharmaceutical and veterinary preparations, etc.
味調製品。(4) A sweetened preparation produced by the sweetening method according to claim 3.
ポリデクストロース、スターチ、マルトデキストリン、
セルロース、メチルセルロース、カルボキシメチルセル
ロース、ハイドロオキシメチルセルロース、微晶質セル
ロース、アルギン酸ソーダ、ペクチン、ガム、ラクトー
ス、マルトーズ、グルコース、ロイシン、グリセロール
、マニトール、ソルビトール、炭酸水素ナトリウム、及
び燐酸、クエン酸、タルタル酸、フマル酸、安息香酸、
ソルビン酸及びプロピオン酸、及びこれらのナトリウム
、カリウム及びカルシウム塩を含む群から選択される担
体或は充填剤とを備えた甘味組成物。(5) an appropriate amount of the sweetener according to claim 1;
polydextrose, starch, maltodextrin,
Cellulose, methylcellulose, carboxymethylcellulose, hydroxymethylcellulose, microcrystalline cellulose, sodium alginate, pectin, gum, lactose, maltose, glucose, leucine, glycerol, mannitol, sorbitol, sodium bicarbonate, and phosphoric acid, citric acid, tartaric acid, fumaric acid, benzoic acid,
A sweetening composition comprising a carrier or filler selected from the group comprising sorbic acid and propionic acid and their sodium, potassium and calcium salts.
、コーンシロップ、フラクトース、アスパラテーム、ア
リテーム、ネオヘスパリジン、ジハイドロカルコーン、
脱水イソマルトース、ステビオサイド、L−砂糖、グリ
シルリジン、キリトール、ソルビトール、マニトール、
アセサルフェーム−K、サッカリン及びこれらのナトリ
ウム、カリウム、アンモニウム或はカルシウム塩、シク
ラメン酸及びこのナトリウム、カリウム、アンモニウム
或はカルシウム塩、トリクロロガラクトサクロース、モ
ネリン及びタウマチンを含む群から選択される他の甘味
剤とを備えた甘味剤。(6) The sweetener according to claim 1, sucrose, corn syrup, fructose, aspartame, alitame, neohesparidin, dihydrochalcone,
Dehydrated isomaltose, stevioside, L-sugar, glycyrrhizin, kylitol, sorbitol, mannitol,
others selected from the group comprising acesulfame-K, saccharin and their sodium, potassium, ammonium or calcium salts, cyclamenic acid and its sodium, potassium, ammonium or calcium salts, trichlorogalactosacrose, monellin and thaumatin; A sweetener comprising a sweetener and a sweetener.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8718114A FR2624699B1 (en) | 1987-12-18 | 1987-12-18 | HETEROCYCLIC DERIVATIVES OF N-CARBAMOYL-, N-THIOCARBAMOYL- OR N-AMIDINO-GLYCINE OR BETA-ALANINE USEFUL AS SWEETENING AGENTS |
FR8718114 | 1987-12-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH022327A true JPH022327A (en) | 1990-01-08 |
Family
ID=9358273
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP63318352A Pending JPH022327A (en) | 1987-12-18 | 1988-12-16 | Sweetener having heterocyclic group |
Country Status (6)
Country | Link |
---|---|
US (1) | US4997667A (en) |
EP (1) | EP0321369A1 (en) |
JP (1) | JPH022327A (en) |
KR (1) | KR890009303A (en) |
AU (1) | AU612739B2 (en) |
FR (1) | FR2624699B1 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH04150512A (en) * | 1990-10-12 | 1992-05-25 | Japan Radio Co Ltd | Surface acoustic wave element |
JP2006515585A (en) * | 2002-12-06 | 2006-06-01 | パーデュー・リサーチ・ファウンデーション | Pyridines for treating damaged mammalian nervous tissue |
JP2010031035A (en) * | 1996-08-12 | 2010-02-12 | Harris Roger | Method of enhancing capacity of anoxic exercise in tissue and composition |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2791156B2 (en) * | 1988-08-23 | 1998-08-27 | ザ ヌトラスウィート カンパニー | Substituted aryl ureas as intense sweeteners |
HU208959B (en) * | 1989-02-03 | 1994-02-28 | Lilly Co Eli | Process for (-)-n"-cyano-n(3-pyridyl)-n'(1,2,2-tri methyl-propyl)-guanidine, it's |
FR2653303B1 (en) * | 1989-10-24 | 1992-09-18 | Noffre Claude | HIGH STABILITY SWEETENERS DERIVED FROM L-ASPARTIC AND L-GLUTAMIC N-HYDROCARBON ACIDS 1-OXO-2-BRANCHED. |
FR2697844B1 (en) * | 1992-11-12 | 1995-01-27 | Claude Nofre | New compounds derived from dipeptides or dipeptide analogues useful as sweetening agents, process for their preparation. |
US5616590A (en) * | 1994-06-30 | 1997-04-01 | Ciba-Geigy Corporation | Plant microbicides |
US5618517A (en) * | 1995-10-03 | 1997-04-08 | Church & Dwight Co., Inc. | Chewing gum product with dental care benefits |
US5693334A (en) * | 1995-10-05 | 1997-12-02 | Church & Dwight Co., Inc. | Chewing gum product with dental health benefits |
EP0784933A3 (en) * | 1995-10-16 | 1997-11-26 | Leaf, Inc. | Extended release of additives in comestible products |
US5629035A (en) * | 1995-12-18 | 1997-05-13 | Church & Dwight Co., Inc. | Chewing gum product with encapsulated bicarbonate and flavorant ingredients |
US5872122A (en) * | 1997-10-16 | 1999-02-16 | Monsanto Company | Pyrimidinylamidino β-amino acid derivatives useful as inhibitors of platelet aggregation |
US6037365A (en) * | 1998-09-25 | 2000-03-14 | G.D. Searle & Co. | Aminobenzamidinosuccinyl lactone derivatives useful as inhibitors of platelet aggregation |
JP2002315521A (en) * | 2001-04-06 | 2002-10-29 | Mcneil Ppc Inc | Multifunctional food base for honey substitute and fluid food |
CN103275058B (en) | 2003-08-06 | 2016-02-24 | 西诺米克斯公司 | Seasonings, taste modulators, tastant, taste enhancer, tasty agents or sweeting agent and/or toughener and uses thereof |
US20060045953A1 (en) * | 2004-08-06 | 2006-03-02 | Catherine Tachdjian | Aromatic amides and ureas and their uses as sweet and/or umami flavor modifiers, tastants and taste enhancers |
JP2008530017A (en) * | 2005-02-04 | 2008-08-07 | セノミックス インコーポレイテッド | Molecules containing organic moieties linked as flavor modifiers for food compositions |
UA88678C2 (en) | 2005-02-04 | 2009-11-10 | Синомикс, Инк. | Comestible composition comprising compound with linked hetero aryl moieties for modifying umami taste and flavour |
AR055329A1 (en) * | 2005-06-15 | 2007-08-15 | Senomyx Inc | BIS-AROMATIC AMIDAS AND ITS USES AS SWEET FLAVORS, FLAVORS, AND FLAVOR ENHANCERS |
US8956677B2 (en) * | 2005-11-23 | 2015-02-17 | The Coca-Cola Company | High-potency sweetener composition with glucosamine and compositions sweetened therewith |
US9101160B2 (en) | 2005-11-23 | 2015-08-11 | The Coca-Cola Company | Condiments with high-potency sweetener |
US8956678B2 (en) * | 2005-11-23 | 2015-02-17 | The Coca-Cola Company | High-potency sweetener composition with preservative and compositions sweetened therewith |
US20070116836A1 (en) * | 2005-11-23 | 2007-05-24 | The Coca-Cola Company | High-Potency Sweetener Composition for Treatment and/or Prevention of Osteoporosis and Compositions Sweetened Therewith |
CA2629556A1 (en) * | 2005-11-23 | 2007-07-19 | The Coca Cola Company | Synthetic sweetener compositions with improved temporal profile and/or flavor profile, methods for their formulation, and uses |
US20070134391A1 (en) * | 2005-11-23 | 2007-06-14 | The Coca-Cola Company | High-Potency Sweetener Composition for Treatment and/or Prevention of Autoimmune Disorders and Compositions Sweetened Therewith |
US8993027B2 (en) * | 2005-11-23 | 2015-03-31 | The Coca-Cola Company | Natural high-potency tabletop sweetener compositions with improved temporal and/or flavor profile, methods for their formulation, and uses |
US20070116822A1 (en) * | 2005-11-23 | 2007-05-24 | The Coca-Cola Company | High-potency sweetener composition with saponin and compositions sweetened therewith |
US20070116825A1 (en) * | 2005-11-23 | 2007-05-24 | The Coca-Cola Company | Confection with High-Potency Sweetener |
US9144251B2 (en) * | 2005-11-23 | 2015-09-29 | The Coca-Cola Company | High-potency sweetener composition with mineral and compositions sweetened therewith |
US20070116831A1 (en) * | 2005-11-23 | 2007-05-24 | The Coca-Cola Company | Dental Composition with High-Potency Sweetener |
EP3398452A3 (en) | 2006-04-21 | 2018-11-28 | Senomyx, Inc. | Comestible compositions comprising high potency savory flavorants, and processes for producing them |
US20080107787A1 (en) * | 2006-11-02 | 2008-05-08 | The Coca-Cola Company | Anti-Diabetic Composition with High-Potency Sweetener |
US8017168B2 (en) | 2006-11-02 | 2011-09-13 | The Coca-Cola Company | High-potency sweetener composition with rubisco protein, rubiscolin, rubiscolin derivatives, ace inhibitory peptides, and combinations thereof, and compositions sweetened therewith |
US9101161B2 (en) * | 2006-11-02 | 2015-08-11 | The Coca-Cola Company | High-potency sweetener composition with phytoestrogen and compositions sweetened therewith |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3492131A (en) * | 1966-04-18 | 1970-01-27 | Searle & Co | Peptide sweetening agents |
US3800046A (en) * | 1967-04-17 | 1974-03-26 | Searle & Co | Artificially sweetened consumable products |
GB1258248A (en) * | 1968-07-17 | 1971-12-22 | ||
US3642491A (en) * | 1970-01-12 | 1972-02-15 | Searle & Co | Artificially sweetened consumable products |
NL8000869A (en) * | 1979-02-16 | 1980-08-19 | Eisai Co Ltd | CYANOGUANIDINE DERIVATIVES AND METHOD FOR THE PREPARATION THEREOF. |
FR2533210A1 (en) * | 1982-09-17 | 1984-03-23 | Lyon I Universite Claude | SWEETENERS OF SYNTHESIS |
FR2579201B1 (en) * | 1985-03-19 | 1987-05-07 | Bernard Lyon I Universite Clau | IMPROVED CHEMICAL COMPOUNDS, USE AS SWEETENING AGENTS AND COMPOSITIONS CONTAINING SUCH AGENTS |
FR2579202B1 (en) * | 1985-03-19 | 1988-04-29 | Univ Claude Bernard Lyon | NOVEL CHEMICAL COMPOUNDS, USE AS SWEETENERS AND COMPOSITIONS CONTAINING SUCH AGENTS |
IL75860A (en) * | 1985-07-21 | 1987-12-20 | Lipski Mordechai | Bathtub seat |
KR870008526A (en) * | 1986-03-13 | 1987-10-19 | 원본미기재 | Sweetener and method for producing the same |
FR2609603B1 (en) * | 1987-01-15 | 1989-03-24 | Univ Claude Bernard Lyon | SWEETENING AGENTS DERIVED FROM GUANIDINOACETIC AND ETHANAMIDINOACETIC ACIDS, METHOD FOR SWEETENING VARIOUS PRODUCTS, AND COMPOSITIONS CONTAINING SUCH SWEETENING AGENTS |
JP2791156B2 (en) * | 1988-08-23 | 1998-08-27 | ザ ヌトラスウィート カンパニー | Substituted aryl ureas as intense sweeteners |
-
1987
- 1987-12-18 FR FR8718114A patent/FR2624699B1/en not_active Expired - Fee Related
-
1988
- 1988-12-14 AU AU26865/88A patent/AU612739B2/en not_active Ceased
- 1988-12-15 EP EP88420421A patent/EP0321369A1/en not_active Ceased
- 1988-12-16 JP JP63318352A patent/JPH022327A/en active Pending
- 1988-12-16 KR KR1019880016919A patent/KR890009303A/en not_active Application Discontinuation
- 1988-12-16 US US07/285,602 patent/US4997667A/en not_active Expired - Fee Related
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH04150512A (en) * | 1990-10-12 | 1992-05-25 | Japan Radio Co Ltd | Surface acoustic wave element |
JP2010031035A (en) * | 1996-08-12 | 2010-02-12 | Harris Roger | Method of enhancing capacity of anoxic exercise in tissue and composition |
JP2006515585A (en) * | 2002-12-06 | 2006-06-01 | パーデュー・リサーチ・ファウンデーション | Pyridines for treating damaged mammalian nervous tissue |
Also Published As
Publication number | Publication date |
---|---|
US4997667A (en) | 1991-03-05 |
EP0321369A1 (en) | 1989-06-21 |
AU612739B2 (en) | 1991-07-18 |
FR2624699A1 (en) | 1989-06-23 |
KR890009303A (en) | 1989-08-01 |
FR2624699B1 (en) | 1990-04-13 |
AU2686588A (en) | 1989-07-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH022327A (en) | Sweetener having heterocyclic group | |
KR100254297B1 (en) | Compounds useful as sweetening agents and process for their preparation | |
US4673582A (en) | Novel sweetening agents, process for sweetening various products and compositions containing such sweetening agents | |
US20040062844A1 (en) | Salts of L-amino acids having improved taste and their preparation | |
JPS6193194A (en) | Alpha-l-aspartyl-d-phenylglycin ester and amide useful as high strength sweetener | |
JPH022326A (en) | Sweetener having heterocyclic group | |
US4877895A (en) | Glycine and β alanine derivatives as sweetening agents | |
EP0417256B1 (en) | Novel n-(sulfomethyl)-n'-arylureas | |
US5968581A (en) | Dipeptide derivatives and sweetening agents | |
US4692513A (en) | Alpha-L-aspartyl-D-heteroaromatic-substituted glycine esters and amides useful as high intensity sweeteners | |
US5773640A (en) | N- N-(3,3-dimethylbutyl)-L-A-aspartyl!-L-hexahydrophenylalanine 1-methyl ester useful as a sweetening agent, its method of preparation | |
JPS63188360A (en) | Sweetener | |
US6649784B2 (en) | Aspartyl dipeptide ester derivatives and sweeteners | |
FR2630304A1 (en) | N-HYDROCARBON DERIVATIVES OF ALPHA-MONOAMIDE ASPARTIC AND GLUTAMIC ACIDS USEFUL AS SWELLING AGENTS | |
US5272272A (en) | Sweetening agents derived from L-glutamic acid | |
JPS61291596A (en) | L-aspartyl-d-alanine-(+), beta-fenchyl ester | |
US4900740A (en) | N,N'-disubstituted guanidines containing a carboxyl or a tetrazolyl moiety | |
KR19990082328A (en) | (N)-(S) -l-phenyl-l-alkanamide (N)-(3,3-dimethylbutyl) -L-aspartyl-D-α aminoalkanoic acid for use as a sweetener | |
JPH0723396B2 (en) | Oxaethyl ester of α-L-aspartyl-D-phenylglycine | |
JPS62132847A (en) | Novel amino acid derivative and sweetener composition | |
JPS6339896A (en) | O-fenchyl ether of l-aspartylserine methyl ester |